EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY-NC-ND 4.0

Comparative efficacy of PUVA therapy and photodynamic therapy in patients with mycosis fungoides: a retrospective cohort study

Olga Yu. Olisova, Ekaterina R. Dunaeva, Konstantin V. Smirnov

Russian Journal of Skin and Venereal Diseases · 18.07.2026 · 29 (5) · 554-565

DOI: 10.17816/dv706778 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Russian Journal of Skin and Venereal Diseases, online erschienen am 18.07.2026. Verfasst von Olga Yu. Olisova und 2 weiteren Autor:innen. Die Arbeit nennt 9 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Mycosis fungoides is the most common form of cutaneous T-cell lymphoma. Phototherapy modalities, including psoralen plus ultraviolet A (PUVA) and photodynamic therapy (PDT), are widely used for early-stage mycosis fungoides. However, comparative data on their efficacy remain limited. AIM: To conduct a comparative retrospective analysis of the efficacy of PUVA therapy and PDT in patients with mycosis fungoides. METHODS: The study included 90 patients with a verified diagnosis of mycosis fungoides: 52 patients received PUVA therapy (4 times weekly; oral Oxsoralen or Ammifurin; initial UVA dose 0.5 J/cm² with gradual increase) and 38 patients received PDT (once weekly; topical spirulina gel with chlorin e6; wavelength 66 ± 2 nm; light dose 200–400 J/cm²). The following outcomes were assessed: rates of complete and partial regression of skin lesions, remission duration, number of sessions, and the influence of age, sex, and lesion type on treatment outcomes. RESULTS: In the PUVA group, complete regression was achieved in 71.2% of patients (37/52), and partial regression in 28.8% (15/52). Median remission duration was 24 months (95% CI 18–30). A strong correlation was found between the number of sessions and remission duration (ρ=0.70; p 0.001). ROC analysis identified a threshold value of ≥25 sessions (sensitivity 83.8%, specificity 66.7%). In the PDT group, no complete regression was observed; partial regression was achieved in 68.4% of patients (26/38), and no effect was observed in 31.6% (12/38). Median remission duration was 12 months (95% CI 11–13). According to Cox regression, PDT was associated with a 2.18-fold increased risk of relapse compared with PUVA (p=0.004). The presence of stage IIB was an unfavorable prognostic factor (HR 1.95; p=0.018). Age and sex did not influence treatment efficacy (p 0.05). CONCLUSION: PUVA therapy is a highly effective treatment for mycosis fungoides, achieving complete regression in 71.2% of patients with a median remission duration of 24 months. PDT using the studied protocol demonstrated significantly lower efficacy (no complete regression, median remission duration of 12 months). A minimum of 25 PUVA sessions is recommended to achieve complete regression.

Zitieren

APA

Olisova, O. Y., Dunaeva, E. R., & Smirnov, K. V. (2026). Comparative efficacy of PUVA therapy and photodynamic therapy in patients with mycosis fungoides: a retrospective cohort study. Russian Journal of Skin and Venereal Diseases, 29(5), 554-565. https://doi.org/10.17816/dv706778

Vancouver

Olisova OY, Dunaeva ER, Smirnov KV. Comparative efficacy of PUVA therapy and photodynamic therapy in patients with mycosis fungoides: a retrospective cohort study. Russian Journal of Skin and Venereal Diseases. 2026;29(5):554-565. doi:10.17816/dv706778

BibTeX
@article{Olisova2026,
  author = {Olisova, Olga Yu. and Dunaeva, Ekaterina R. and Smirnov, Konstantin V.},
  title = {Comparative efficacy of PUVA therapy and photodynamic therapy in patients with mycosis fungoides: a retrospective cohort study},
  journal = {Russian Journal of Skin and Venereal Diseases},
  year = {2026},
  volume = {29},
  number = {5},
  pages = {554--565},
  doi = {10.17816/dv706778}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche